Articles overview
Measurable Residual Disease and Decision-Making in Multiple Myeloma
An excellent, must-read review article has been published by Benjamin Derman and Rafael Fonseca with a deep-dive into the evolving...
Read more
Hypogammaglobulinemia newsletter
Welcome to this edition of the Sanofi quarterly newsletter! These newsletters, created by Sanofi, aim to provide education to healthcare...
Read more
Risk stratification in patients with monoclonal Gammopathies
Thorsteinsdóttir, S., Gíslason, G., Aspelund, T. et al. Prevalence of smoldering multiple myeloma based on nationwide screening. Nature Medicine. 2023;...
Read more
Review: NK cell therapy in relapsed refractory multiple myeloma
Read the review about NK cell therapy in relaped refractory multiple Myeloma from Science direct
Read more
Personalized Medicine
Patient-derived multiple myeloma 3D models for personalized medicine
Read more